Headlines about Simulations Plus (NASDAQ:SLP) have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern scores the sentiment of news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Simulations Plus earned a news impact score of 0.12 on Accern’s scale. Accern also assigned media stories about the technology company an impact score of 44.5510812184361 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
A number of analysts have recently issued reports on SLP shares. Zacks Investment Research downgraded Simulations Plus from a “hold” rating to a “sell” rating in a research report on Friday, December 22nd. BidaskClub raised Simulations Plus from a “hold” rating to a “buy” rating in a report on Saturday, February 24th.
Simulations Plus (NASDAQ SLP) traded down $0.03 on Wednesday, hitting $15.97. The stock had a trading volume of 4,765 shares, compared to its average volume of 51,943. Simulations Plus has a 52-week low of $10.10 and a 52-week high of $17.45. The stock has a market capitalization of $283.60, a PE ratio of 46.00 and a beta of -0.63.
In other Simulations Plus news, CEO Walter S. Woltosz sold 18,500 shares of the company’s stock in a transaction dated Wednesday, December 27th. The stock was sold at an average price of $16.25, for a total value of $300,625.00. Following the completion of the sale, the chief executive officer now owns 5,502,416 shares in the company, valued at $89,414,260. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In the last quarter, insiders have sold 55,500 shares of company stock valued at $899,655. 33.45% of the stock is owned by company insiders.
ILLEGAL ACTIVITY WARNING: “Somewhat Positive Press Coverage Somewhat Unlikely to Impact Simulations Plus (SLP) Stock Price” was first posted by BBNS and is the sole property of of BBNS. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://baseballnewssource.com/2018/03/14/simulations-plus-slp-receiving-somewhat-favorable-press-coverage-analysis-finds/1923652.html.
About Simulations Plus
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.